About HUNT Biosciences

HUNT Biosciences was established in 2007 in order to offer a professional interface with industry and facilitate commercial use of HUNT data and samples, without compromising the trust of the donor population. HUNT Biosciences is a public company owned by the Norwegian University of Science and Technology (NTNU), the Central Norway Regional Health Authority and the North Trøndelag County.

HUNT Biosciences offers the life-science and biopharma industry unique access to the HUNT Bio- and Databank, a fully established Norwegian-population-based prospective health survey and biobank. The HUNT Databank comprises more than 5,500 data variables, medical records, clinical measurements, environmental exposures, and biological samples collected through 30 years in three phases from a regional cohort of 130,000 individuals.

The HUNT Study is one of the largest and most comprehensive population-based health studies ever performed. By international standards, the participation rates have been astonishingly high — over 85%. Thus, unlike many other biobanks, the HUNT Bio- and Databank gives a truly representative picture of a general population. Entirely voluntary and approved by ethical authorities, the potential benefits for medical research of such a cohort is obvious – and indeed has already generated more than 700 peer reviewed scientific papers and 67 PhDs.